Shen Minna, Shen Minqiang
Department of Surgery, Huzhou Third Municipal Hospital, the Affiliated Hospital of Huzhou University, Huzhou City, Zhejiang Province, China.
Department of Critical Care Medicine, Huzhou Third Municipal Hospital, the Affiliated Hospital of Huzhou University, Huzhou City, Zhejiang Province, China.
PLoS One. 2025 May 13;20(5):e0323237. doi: 10.1371/journal.pone.0323237. eCollection 2025.
Ureterorenoscopy (URS) is a common procedure performed for renal or upper ureteric stones. Nevertheless, the efficacy and safety of URS in the elderly is unclear. We conducted the first meta-analysis of literature comparing outcomes of URS between elderly and non-elderly patients.
Embase, PubMed, Web of Science, and Scopus databases were searched for studies relevant to the review. The last date was 2nd September 2024. The elderly were defined as ≥ 65 or 60 years of age. Outcomes compared were stone-free rates (SFR), complications, and length of hospital stay (LOS).
Nine studies met the inclusion criteria. Pooled analysis showed that there was no difference in SFR between elderly and non-elderly groups after URS (OR: 0.96 95% CI: 0.81, 1.14 I2 = 3%). Meta-analysis failed to show any statistical significant in all complication rates (OR: 1.04 95% CI: 0.77, 1.40 I2 = 51%) as well as infectious (OR: 1.27 95% CI: 0.84, 1.92 I2 = 0%), medical (OR: 2.01 95% CI: 0.23, 17.57 I2 = 93%), surgical (OR: 1.18 95% CI: 0.68, 2.03 I2 = 0%) or Clavein Dindo grade ≥2 (OR: 1.02 95% CI: 0.60, 1.75 I2 = 0%) complications between elderly and non-elderly groups. Meta-analysis showed that the elderly had significantly longer LOS as compared to non-elderly patients (MD: 0.75 95% CI: 0.05, 1.45 I2 = 90%).
URS seems to efficacious and safe in the elderly. Patients ≥60 or 65 years of age have similar SFR and complication rates as younger patients. However, LOS may be increased in the elderly. More robust studies taking into account baseline characteristics and importantly presenting rates are needed to validate the current results.
输尿管肾镜检查(URS)是治疗肾或上段输尿管结石的常见手术。然而,URS在老年患者中的疗效和安全性尚不清楚。我们首次对比较老年和非老年患者URS治疗结果的文献进行了荟萃分析。
检索Embase、PubMed、Web of Science和Scopus数据库中与该综述相关的研究。最后检索日期为2024年9月2日。将年龄≥65岁或60岁定义为老年人。比较的结果包括结石清除率(SFR)、并发症和住院时间(LOS)。
9项研究符合纳入标准。汇总分析显示,URS术后老年组和非老年组的SFR无差异(OR:0.96,95%CI:0.81,1.14;I2 = 3%)。荟萃分析未显示所有并发症发生率(OR:1.04,95%CI:0.77,1.40;I2 = 51%)以及感染性(OR:1.27,95%CI:0.84,1.92;I2 = 0%)、内科(OR:2.01,95%CI:0.23,17.57;I2 = 93%)、外科(OR:1.18,95%CI:0.68,2.03;I2 = 0%)或Clavein Dindo≥2级(OR:1.02,95%CI:0.60,1.75;I2 = 0%)并发症在老年组和非老年组之间有任何统计学显著差异。荟萃分析表明,与非老年患者相比,老年患者的LOS显著更长(MD:0.75,95%CI:0.05,1.45;I2 = 90%)。
URS在老年患者中似乎有效且安全。60岁或65岁及以上的患者与年轻患者的SFR和并发症发生率相似。然而,老年患者的LOS可能会增加。需要更有力的研究,考虑基线特征并重要地呈现发生率,以验证当前结果。